Testing effectiveness (Phase 2)Study completedNCT03276013
What this trial is testing
Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer
Who this might be right for
Endometrial Neoplasms
Vall d'Hebron Institute of Oncology 48